Injector device with flow path and drive
10828421 ยท 2020-11-10
Assignee
Inventors
Cpc classification
A61M5/3134
HUMAN NECESSITIES
B29C33/12
PERFORMING OPERATIONS; TRANSPORTING
B65D25/108
PERFORMING OPERATIONS; TRANSPORTING
B65D5/503
PERFORMING OPERATIONS; TRANSPORTING
A61M5/3202
HUMAN NECESSITIES
A61M2005/312
HUMAN NECESSITIES
A61M5/31511
HUMAN NECESSITIES
A61M2005/31516
HUMAN NECESSITIES
A61M5/1456
HUMAN NECESSITIES
B65D1/36
PERFORMING OPERATIONS; TRANSPORTING
A61M5/28
HUMAN NECESSITIES
A61M5/34
HUMAN NECESSITIES
A61M2005/341
HUMAN NECESSITIES
B29L2031/7544
PERFORMING OPERATIONS; TRANSPORTING
A61M2207/00
HUMAN NECESSITIES
International classification
A61M5/28
HUMAN NECESSITIES
A61M5/32
HUMAN NECESSITIES
A61M5/34
HUMAN NECESSITIES
B65D5/50
PERFORMING OPERATIONS; TRANSPORTING
B65D21/02
PERFORMING OPERATIONS; TRANSPORTING
B65D1/36
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A device for drug injection has a cartridge, which in turn has a reservoir and a fluid path. The fluid path carries a fluid for injection from the reservoir to the place where the patient is to be injected. The fluid path comprises a needle, and the fluid path is kept sterile. A drive chain extends the needle to the injection point, but is only mechanically connected to the fluid path to operate the needle, the mechanical connection being such as to operate the needle while maintaining the fluid path sterility.
Claims
1. A device for drug injection comprising: a cartridge comprising a reservoir having a lengthwise axis and an injection needle extending from, and formed in one piece with, the reservoir, a portion of the injection needle being bent relative to the lengthwise axis, the reservoir and the injection needle defining a fluid path to carry an injection fluid from the reservoir to a patient at an injection point, the cartridge, including the reservoir, the injection needle and the injection fluid therein, being insertable and removable from the device in a sealed, sterile state; and a drive chain mechanically connected to the inserted cartridge, the drive chain comprising a coiled spring and a motion translation unit configured to translate rotary uncoiling of the spring to a lowering motion of the cartridge and needle to move the needle to the injection point, the mechanical connection between the drive chain and the cartridge being external to the fluid path, thereby maintaining the fluid path sterility.
2. The device of claim 1, wherein said fluid path is pre-shaped to contain an angle.
3. The device of claim 1, wherein said drive chain is disconnectable from said fluid path while maintaining said fluid path sterility.
4. The device of claim 1, further comprising a housing and a button to operate said drive chain, the housing being shaped and sized to be held in a one handed grip, the button being positioned to be operated by fingers of said one-handed grip.
5. The device of claim 4, having a front end and a rear end and an adhesive layer for attachment to skin of said patient for said injection.
6. The device of claim 5, the device being attachable and detachable to said patient via said adhesive layer using said one-handed grip and a rolling motion between said front end and said rear end.
7. The device of claim 1, further comprising a cover in said housing, the cover being removable to allow removal of said reservoir via said housing.
8. The device of claim 7, wherein said reservoir is removable with said fluid path.
9. A method for filling, loading and removing a cartridge in an injector device wherein the cartridge is mounted lengthwise in the injector device at an angle to a plane of skin of a patient receiving an injection, the method comprising: obtaining a cartridge comprising a reservoir having a lengthwise axis and an injection needle extending from, and formed in one piece with, the reservoir, the reservoir and injection needle defining a fluid path for carrying fluid from the cartridge to an injection site; bending the injection needle and forming an angle therein such that said fluid path bends from extending along the lengthwise axis of said reservoir into a direction substantially perpendicular to said plane of the skin; filling said cartridge with injection fluid after the forming step; loading said cartridge, with said fluid path, into said injector device; uncoiling a coiled spring, whereby a motion translation unit translates rotary uncoiling of the spring to a lowering motion of the cartridge and needle to move the needle to an injection point; and removing said cartridge from said injector device.
10. The method of claim 9, comprising carrying out said removing upon noticing a fault in said injector device, and placing said cartridge in a second injector device.
11. The method of claim 9, comprising carrying out said removing upon noticing a fault in said reservoir, and placing another cartridge in said injector device.
12. The method of claim 9, comprising providing a housing for said injector device and a removable cover in said housing and opening said removable cover to carry out said loading and said removing.
13. The method of claim 9, wherein said loading step comprises placing said fluid path in mechanical connection with a drive mechanism configured to move the injection needle to an injection site on said patient.
14. The method of claim 13, wherein said fluid path is sterile, and the method further comprising connecting and disconnecting the drive mechanism while retaining said fluid path sterility.
Description
BRIEF DESCRIPTION OF THE SEVERAL VIEWS OF THE DRAWING(S)
(1) Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.
(2) In the drawings:
(3)
(4)
(5)
(6)
(7)
(8)
(9)
(10)
(11)
(12)
DESCRIPTION OF SPECIFIC EMBODIMENTS OF THE INVENTION
(13) The present invention, in some embodiments thereof; relates to an injector device with a flow path for the material to be injected and a drive mechanism for extending and retracting the needle, and, more particularly, but not exclusively, to an arrangement for ensuring the sterility of the flow path.
(14) Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.
(15) Referring now to the drawings,
(16) The cartridge 12 has a barrel reservoir 18 for holding the fluid to be injected and a fluid path 20 for carrying the fluid from the reservoir 18 to the point of injection. The fluid path comprises a needle, not shown in this figure, under a needle cover 22. The fluid path is kept sterile by being sealed from the device, and the only contacts with the device are mechanical contacts which act through the seal without compromising the integrity of the seal and thus of the sterility. Thus the device 10 as a whole need not be sterile. As a result the cartridge can be inserted and removed without compromising its sterility.
(17) Cog 24 is engaged by a mechanism, typically an electric motor to push a plunger within the bagel to carry out the injection. Engagement frame 26 on the cartridge engages a holding recess 25 within the device to position the cartridge correctly.
(18) Reference is now made to
(19) The drive chain is mechanically connected to the fluid path to operate the needle. The mechanical connection simply pushes on the fluid path from the outside and does not compromise the sterility within the fluid path. The mechanical connection thus operates the needle while maintaining the fluid path sterility.
(20) One non-limiting embodiment of the drive chain is now described with reference to
(21) A motion source may be provided to operate the needle 60. The motion source may in one embodiment be a tensioned wheel 62. In other embodiments a plunger may be pushed by a spring. The tensioned wheel may comprise two lugs 64 and 66 which interrupt the motion of the wheel.
(22) A user-operated control for the motion source may comprise button 68. It is noted that the button may be a separate component that is compressible or it may be a flexible part of the housing that can be pressed. As the button is pressed once, the first lug 64 is released, allowing the wheel to rotate half a turn. The motion of the half turn is translated into an insertion motion for needle 60, thus inserting the needle. In an embodiment, the button 68 is a separate component from the device housing, so that the housing shields the button from accidental pressing. To reach the button, the cover part of the housing may be lowered, thus providing a two stage activation system and adding safety to the device.
(23) The second lug 66 then serves as an interrupter, stopping motion of the wheel at a preset location at which the insertion motion of the needle is complete. The second lug thus divides the wheel motion into a first motion part and a second motion part, the two motion parts being in continuity with each other.
(24) A second wheel may be provided on the other side of the button 68, not visible in the present figure, to provide more balanced motion.
(25) As the wheel is released a second time, it rotates from the second lug to the first lug on the second part of a complete rotation, and the motion is translated into retraction of the needle.
(26) In an alternative embodiment, the needle may not be retracted, but rather the base may extend to shield the needle when the device is removed from the skin.
(27) Alternatively or additionally, the linear movement of the needle retraction may for example be by means of multiple actuators or springs moving the needle in opposite directions. In some embodiments, the activation button may return to the original position and/or be locked after injection.
(28) Alternatively or additionally, needle retraction may be activated by a switch. For example there may be a needle retraction switch and/or after needle insertion the activation button may be reused as a needle retraction switch.
(29) A motion translation mechanism to be discussed in greater detail below, connects the wheel or any other source of the continuous motion to the needle 60. The motion translation mechanism may insert the needle during the first motion part and may retract the needle during the second motion part.
(30) In the case of a wheel as the motion source, the continuity of the motion is angular.
(31) As will be discussed below, instead of or in addition to a wheel with lugs, a suitably shaped cam may be used.
(32) Thus the device has a housing, and button 68 which operates the drive chain as will be described in greater detail below. The housing is shaped and sized to be held in a one handed grip, in the same way that a computer mouse is so designed. The button is positioned with the one-handed grip in mind to be operated by the fingers while in the one-handed grip.
(33) The device may have an adhesive layer at the base for attachment to the skin of the patient so as to hold the device still for the duration of the injection. For certain injections there may be a need to inject slowly so the device needs to be in the same position for several minutes. Preferably, the device is attachable and detachable via the adhesive layer using the one-handed grip and a rolling motion between the front and back of the device. Thus the device is firmly positioned and adhered and then peeled off after use.
(34) As mentioned, the cover 16 may be removable to allow loading and removal of the reservoir via the opening made in the housing.
(35) The entire cartridge is removed, thus taking out the reservoir with the accompanying fluid path.
(36) Reference is now made to
(37) Lugs 62 and 64 are optional and may be omitted in some embodiments. However an element is required which is responsible to prevent the cover from being lowered prior to use. Such an element may be a contact between the button and the structure (base/cover) or the wheel lug 62, 64 or the pin 70. A second element or contact is responsible for preventing movement when the wheel is held in the lower or extended position. Again the feature may be provided by the contact between the safety latch lug and wheel pin, A third element/contact is responsible for arresting motion at the end of travel, thus ensuring that the needle, once retracted, cannot be extended again. Such a feature may be provided by contact between the wheel lug or wheel pin and the structure.
(38) Reference is now made to
(39) Reference is now made to
(40) Reference is now made to
(41) Reference is now made to
(42) Reference is now made to
(43) Reference is now made to
(44) Reference is now made to
(45) Reference is now made to
(46) Reference is now made to
(47) Reference is now made to
(48) The safety latch thus ensures that the button cannot be pressed unless the injector is placed flush against a flat surface. The safety latch mechanism is not restricted to the present embodiments but is suitable for any kind of injector which is placed flush against the patient's skin. More generally, the safety latch is a latching mechanism for preventing extension of the needle except in the presence of skin, and comprises a lever, namely safety latch 196, having an arm 197, the lever extending at a predetermined angle below the base of the drug delivery device to insert the arm to prevent motion of the user-operated control, namely button 192, to render the button inoperable. The lever is displaced from the predetermined angle shown in
(49)
(50)
(51)
(52)
(53) In the above embodiment, the Base 196 acted as a mechanical proximity sensor. The Base 196 may be used by changing its angle relate to the body, to detect skin proximity and to release the wheel, or the interrupter on the wheel, to cause the second motion part on detecting of removal of the device from the user's skin. Thus the retraction of the needle occurs automatically upon removal of the device from the user. As above the proximity sensor is mechanical but an optical or infrared proximity sensor may also be used and electronically actuate the wheel release.
(54)
(55) In some embodiments syringe 200 may include asymmetric features. For example, the fluid path may be connected non-centrically to the distal end of barrel 242. For example extension 236 projects from a distal end 209 of barrel 242. Optionally the connection between extension 236 and barrel 242 is biased to the dorsal side 239a of barrel 242. In some embodiments a needle cap 204 is mounted on extension 236 at an approximately right angle to axis 258. For example cap 204 faces towards the ventral side 239b of barrel 242. Optionally extension 236 and/or the mount for cap 204 is set back from a ventral side 239b of barrel 242. For example setting back extension 236 and/or the mount for cap 204 may facilitate designing a device with a lower profile (for example because the length of the mounting does not add to the profile of the device). Optionally syringe 200 may include a tab 248 and/or an indentation 238 and/or a protuberance and/or a cut out 244 and/or a beveled part 246 to facilitate attachment of syringe 200 to the drug delivery device.
(56) In some embodiments an indentation and/or an indentation and/or a protuberance may be used to position syringe 200 and/or a cartridge in a delivery device. For example indentation 238 is conical and may interact with a protuberance and/or indentation in the delivery device to position the distal end 209 of the cartridge into alignment with the delivery device. For example an indentation and/or protuberance could include a pin and/or a matching hole. A bevel 246 and and/or cutout 244 and/or tab 248 may optionally interact with a complementary part in a delivery device.
(57) In some embodiments a fluid path 250 connecting between cavity 232 of barrel 242 and extension 236 may pass through and/or be molded into syringe 200. Optionally (for example as illustrated in
(58) In some embodiments, a beveled needle tip 254 is oriented to avoid obstruction of needle 252, as discussed above. For example, the opening of beveled needle tip 254 is directed distally. In the case where needle tip 254 is inserted into a subject by pivoting around the proximal end of the syringe and/or tends to plow proximally as it is inserted into the subject, facing the opening distally may prevent needle obstruction.
(59) In some embodiments an extension may have a non-uniform cross section. For example in the center section of extension 236 windows or holding channels 237 are formed. Optionally holding channels 237 are formed around needle supports that hold the needle during the molding process and are subsequently removed. Optionally the reservoir end of needle 252 may be supported by a core pin. For example, a space 256 left by the core pin in the molded syringe can be seen in
(60) In some embodiments, the size of the core pin holding the end of needle 252 in cavity 232 is made small to reduce the dead space 256 left over after molding. For example a core pin may have a concave and/or conical inner face that grasps the end of needle 252. Alternatively or additionally, a core pin may have a convex and/or conical face that fits into the hollow of needle 252. For example a core pin may include an inner convex portion that fits into the needle 252 and/or an outer concave portion that positions needle 252. Before molding, the outer concave portion of the core pin may position needle 252 in order to insert the inner convex portion of the core pin into the hollow of needle 252. Then the outer concave portion may be retracted before molding. Optionally during molding only the inner portion of the core pin remains in the mold. After molding the inner core pin is optionally removed leaving a reduced dead space when a drug is discharged from the syringe.
(61) In some embodiments, extension 236 has an I-beam cross section as explained. Optionally ribs 235 are offset from the fluid pathway. For example the offset is sufficient to leave space for channels 237 around fluid path 250 and/or between ribs 235.
(62) In some embodiments the end of extension 236 includes a mount for needle cap 204. For example the mount may include a sealing ring 260 and/or a tapered section 261. For example, sealing ring 260 may seal against the inside of cap 204. In some embodiments this may isolate protruding section 251 of needle 252 and/or protect it from contamination. For example, tapered portion 261 may be formed in ribs 235. In some embodiments, tapered section 261 may hold cap 204 rigidly to extension 236. Cap 204 may optionally be connected and/or disconnected from extension 236 by pulling and/or pushing cap 204 along the axis of extension 236 and/or along the axis of protruding section 251 of needle 252.
(63) Thus, as shown, the fluid path may contain an angle. The mechanical connection is designed to allow the drive chain to be separated from said fluid path while maintaining said fluid path sterility.
(64) Reference is now made to
(65) Reference is now made to
(66) As discussed above, removal is carried out via an opening in the housing which is opened by removal of a removable cover.
(67) Loading the cartridge into the injector may involve placing the fluid path in mechanical connection with a drive mechanism. The drive mechanism then operates to extend the needle of the fluid path to an injection site under the patient's skin.
(68) The fluid path may be sterile and sealed, and the fluid path is merely in contact with the drive chain or mechanism externally, so that applying and removing the mechanical connection may be carried out while retaining fluid path sterility. The ability to separate the cartridge, which may have biologically active materials, from the rest of the injector means that a more environmentally friendly disposal procedure may be used, as well as allowing for replacement of the cartridge or injector in the event of a fault.
(69) The terms comprises, comprising, includes, including, having and their conjugates mean including but not limited to.
(70) The term consisting of means including and limited to.
(71) The term consisting essentially of means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.
(72) As used herein, the singular form a, an and the include plural references unless the context clearly dictates otherwise.
(73) It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.
(74) Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.
(75) All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.